Deconinck, E <br/><br/>
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan).  [electronic resource] 

 -  Bone marrow transplantation  Nov 1997 
 - 731-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1700964  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation<br/>Burkitt Lymphoma--radiotherapy<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cytarabine--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Leukemia-Lymphoma, Adult T-Cell--radiotherapy<br/>Male<br/>Melphalan--therapeutic use<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--radiotherapy<br/>Whole-Body Irradiation